Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind vehicle-controlled study of IDP-126 Gel in acne vulgaris
2021-000100-37Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clindamycin phosphate + adapalene + benzoyl peroxide in acne vulgaris (3 arms), sponsored by Valeant Pharmaceuticals. Primary endpoint: Primary comparison of IDP-126 Gel versus Epiduo Forte Gel and vehicle. Started Nov 2021; status: completed.
02
Drugs
clindamycin phosphate + adapalene + benzoyl peroxide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2021-000100-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000100-37.